Australia's most trusted
source of pharma news
Thursday, 22 January 2026
Posted 21 January 2026 AM
Regeneron's Co-Founder and Chief Scientific Officer George Yancopoulos has delivered some harsh words for competitors trying to steal "a slice of the pie" when it comes to blockbuster drugs.
In a sideline interview with Endpoint News at last week's J.P Morgan conference, Yancopoulos didn't hold back pointing the finger at industry players trying to move on the company's immunology blockbuster Dupixent.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.